1. Home
  2. LAW vs ASMB Comparison

LAW vs ASMB Comparison

Compare LAW & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.77

Market Cap

466.2M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$27.41

Market Cap

414.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
ASMB
Founded
2013
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.2M
414.7M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
LAW
ASMB
Price
$3.77
$27.41
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$9.00
$43.40
AVG Volume (30 Days)
286.9K
98.0K
Earning Date
02-25-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,677,000.00
$37,191,000.00
Revenue This Year
$8.54
$33.33
Revenue Next Year
$9.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
31.30
52 Week Low
$3.31
$7.75
52 Week High
$9.11
$39.71

Technical Indicators

Market Signals
Indicator
LAW
ASMB
Relative Strength Index (RSI) 14.85 44.89
Support Level $3.61 $25.14
Resistance Level $6.52 $27.48
Average True Range (ATR) 0.41 1.71
MACD -0.26 0.20
Stochastic Oscillator 5.02 46.51

Price Performance

Historical Comparison
LAW
ASMB

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: